LIVE Symposium
Thursday, May 12, 2021
10:30 AM - 1:30 PM Eastern Time
Immunotherapy holds great promise, but it only works in a subset of cancer patients. To predict which patients will respond positively to certain treatments and track their progress, researchers search for predictive and prognostic immuno-oncology biomarkers.
In this virtual symposium brought to you by The Scientist, an expert panel will discuss their efforts to identify new biomarkers for various cancers, including non-small cell lung cancer (NSCLC) and clear cell renal cell carcinoma (ccRCC). They will also highlight the cutting-edge technologies they use to develop clinical applications for these biomarkers.
Symposium program
10:30 AM – Introduction
10:40 AM – An Immune Cell Signature to Predict Patient Responses to Immunotherapy
Thomas U. Marron, MD, PhD
11:10 AM – How Computational Modeling Informs Trial Design and Biomarker Discovery
Johannes Textor, PhD
11:40 AM – Anti-PD-1 Response and Resistance ...
